Sales of emergency contraception are estimated to rise by around 10% in the US in the week after the New Year holiday, suggesting that this period is associated with increased risks of unprotected sex compared with other holidays, finds a study published in the Christmas issue of The BMJ.
Astellas developing new gastric cancer drug
Astellas Pharma Inc. has submitted a new drug application (NDA) to Japan’s Ministry of Health, Labour and Welfare (MHLW) for zolbetuximab. Zolbetuximab is a first-in-class
June 9, 2023